A randomized phase 2, single-blind study of temozolomide (TMZ) and radiotherapy (RT) combined with nivolumab or placebo (PBO) in newly diagnosed adult patients (pts) with tumor O6-methylguanine DNA methyltransferase (MGMT)-methylated glioblastoma (GBM)—CheckMate-548

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Weller, M; Vlahovic, G; Khasraw, M; Brandes, AA; Zwirtes, R; Tatsuoka, K; Carpentier, AF; Reardon, DA; Bent, M

Published Date

  • October 1, 2016

Published In

Volume / Issue

  • 27 /

Start / End Page

  • vi113 -

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

International Standard Serial Number (ISSN)

  • 0923-7534

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdw367.34

Citation Source

  • Scopus